| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Public Health Professional | 2 | 2014 | 6 | 0.850 |
Why?
|
| Atrial Fibrillation | 18 | 2015 | 738 | 0.830 |
Why?
|
| Cardiovascular Diseases | 31 | 2016 | 2121 | 0.820 |
Why?
|
| Metabolic Syndrome | 14 | 2017 | 369 | 0.720 |
Why?
|
| Coronary Disease | 13 | 2010 | 624 | 0.590 |
Why?
|
| Risk Factors | 66 | 2021 | 11074 | 0.500 |
Why?
|
| Professional Competence | 2 | 2014 | 97 | 0.490 |
Why?
|
| Blood Pressure | 18 | 2016 | 1345 | 0.490 |
Why?
|
| Arginine | 7 | 2014 | 340 | 0.470 |
Why?
|
| Teaching | 2 | 2014 | 196 | 0.470 |
Why?
|
| Hypertension | 18 | 2015 | 1356 | 0.450 |
Why?
|
| Multivariate Analysis | 17 | 2017 | 1378 | 0.440 |
Why?
|
| Longitudinal Studies | 23 | 2021 | 1490 | 0.430 |
Why?
|
| Biostatistics | 1 | 2014 | 10 | 0.420 |
Why?
|
| Massachusetts | 20 | 2017 | 122 | 0.420 |
Why?
|
| Learning | 2 | 2014 | 356 | 0.410 |
Why?
|
| Middle Aged | 86 | 2017 | 28601 | 0.410 |
Why?
|
| Insulin Resistance | 11 | 2014 | 690 | 0.400 |
Why?
|
| Periodicals as Topic | 1 | 2016 | 182 | 0.400 |
Why?
|
| Incidence | 33 | 2017 | 3360 | 0.370 |
Why?
|
| Adipokines | 3 | 2017 | 119 | 0.360 |
Why?
|
| Biomarkers | 20 | 2017 | 3385 | 0.350 |
Why?
|
| Models, Statistical | 4 | 2014 | 483 | 0.350 |
Why?
|
| Aged | 64 | 2017 | 21025 | 0.340 |
Why?
|
| Proportional Hazards Models | 22 | 2017 | 1410 | 0.330 |
Why?
|
| Body Mass Index | 18 | 2017 | 1717 | 0.330 |
Why?
|
| Alcohol Drinking | 4 | 2021 | 341 | 0.330 |
Why?
|
| Male | 100 | 2020 | 64957 | 0.330 |
Why?
|
| Female | 104 | 2022 | 70963 | 0.330 |
Why?
|
| Biomedical Research | 1 | 2016 | 561 | 0.320 |
Why?
|
| Cohort Studies | 31 | 2017 | 5063 | 0.320 |
Why?
|
| Adiponectin | 6 | 2017 | 123 | 0.310 |
Why?
|
| Obesity | 14 | 2018 | 2426 | 0.310 |
Why?
|
| Risk Assessment | 14 | 2015 | 3711 | 0.310 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2011 | 1459 | 0.300 |
Why?
|
| Stroke | 8 | 2017 | 1061 | 0.300 |
Why?
|
| Aging | 6 | 2014 | 1242 | 0.290 |
Why?
|
| Humans | 114 | 2022 | 131163 | 0.290 |
Why?
|
| Gonadal Steroid Hormones | 3 | 2014 | 82 | 0.280 |
Why?
|
| Adult | 57 | 2021 | 31282 | 0.270 |
Why?
|
| Heart Failure | 11 | 2016 | 2332 | 0.260 |
Why?
|
| Cross-Sectional Studies | 24 | 2022 | 3829 | 0.260 |
Why?
|
| Ventricular Remodeling | 5 | 2014 | 155 | 0.250 |
Why?
|
| Prospective Studies | 27 | 2021 | 6459 | 0.230 |
Why?
|
| Follow-Up Studies | 23 | 2017 | 5196 | 0.230 |
Why?
|
| Predictive Value of Tests | 7 | 2017 | 2304 | 0.220 |
Why?
|
| Primary Health Care | 2 | 2001 | 775 | 0.210 |
Why?
|
| Knowledge | 2 | 2014 | 47 | 0.210 |
Why?
|
| Cognition Disorders | 5 | 2007 | 556 | 0.210 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2015 | 362 | 0.200 |
Why?
|
| Tobacco Smoking | 2 | 2021 | 21 | 0.200 |
Why?
|
| Stillbirth | 2 | 2022 | 95 | 0.200 |
Why?
|
| Biometry | 1 | 2004 | 101 | 0.200 |
Why?
|
| Goals | 2 | 2014 | 126 | 0.200 |
Why?
|
| Homocysteine | 5 | 2011 | 116 | 0.190 |
Why?
|
| Leptin | 4 | 2017 | 218 | 0.190 |
Why?
|
| Gonadotropins | 2 | 2013 | 31 | 0.190 |
Why?
|
| Motivation | 2 | 2014 | 328 | 0.180 |
Why?
|
| Resistin | 3 | 2011 | 30 | 0.180 |
Why?
|
| Smoking | 8 | 2017 | 932 | 0.180 |
Why?
|
| Sex Factors | 13 | 2016 | 1356 | 0.180 |
Why?
|
| Carbonated Beverages | 2 | 2014 | 11 | 0.170 |
Why?
|
| Child Health | 1 | 2022 | 72 | 0.170 |
Why?
|
| Community Health Workers | 1 | 2022 | 87 | 0.170 |
Why?
|
| Magnesium | 2 | 2012 | 114 | 0.170 |
Why?
|
| Hospitals, Municipal | 1 | 2001 | 2 | 0.170 |
Why?
|
| Diabetic Angiopathies | 3 | 2007 | 66 | 0.170 |
Why?
|
| Electrocardiography | 6 | 2015 | 970 | 0.160 |
Why?
|
| Aged, 80 and over | 20 | 2015 | 6797 | 0.160 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2001 | 71 | 0.160 |
Why?
|
| Diabetes Mellitus | 8 | 2017 | 889 | 0.160 |
Why?
|
| Retinol-Binding Proteins, Plasma | 3 | 2017 | 16 | 0.160 |
Why?
|
| alpha-2-HS-Glycoprotein | 3 | 2017 | 8 | 0.160 |
Why?
|
| Epidermolysis Bullosa Simplex | 1 | 2020 | 6 | 0.160 |
Why?
|
| Desmoplakins | 1 | 2020 | 12 | 0.160 |
Why?
|
| Violence | 1 | 2001 | 129 | 0.150 |
Why?
|
| Fatty Acid-Binding Proteins | 3 | 2017 | 38 | 0.150 |
Why?
|
| Echocardiography | 5 | 2014 | 1125 | 0.150 |
Why?
|
| Ectodermal Dysplasia | 1 | 2020 | 62 | 0.150 |
Why?
|
| Models, Biological | 1 | 2004 | 1371 | 0.150 |
Why?
|
| Cholesterol, HDL | 7 | 2011 | 383 | 0.150 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2021 | 237 | 0.140 |
Why?
|
| Curriculum | 2 | 2014 | 798 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 325 | 0.140 |
Why?
|
| Vascular Stiffness | 2 | 2016 | 76 | 0.140 |
Why?
|
| Thyroiditis | 1 | 2017 | 3 | 0.140 |
Why?
|
| Goiter | 1 | 2017 | 9 | 0.140 |
Why?
|
| Factor IX | 1 | 2017 | 17 | 0.130 |
Why?
|
| Pregnancy Outcome | 2 | 2021 | 623 | 0.130 |
Why?
|
| Hemophilia B | 1 | 2017 | 12 | 0.130 |
Why?
|
| Linear Models | 7 | 2015 | 688 | 0.130 |
Why?
|
| Thyroid Nodule | 1 | 2017 | 21 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2012 | 324 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2009 | 639 | 0.130 |
Why?
|
| Hypertrophy, Left Ventricular | 4 | 2015 | 108 | 0.130 |
Why?
|
| Child of Impaired Parents | 1 | 2017 | 20 | 0.130 |
Why?
|
| Carcinoma, Papillary | 1 | 2017 | 91 | 0.130 |
Why?
|
| Behavior Therapy | 2 | 2018 | 273 | 0.130 |
Why?
|
| Genome-Wide Association Study | 3 | 2014 | 1833 | 0.130 |
Why?
|
| Heart Ventricles | 4 | 2009 | 749 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2000 | 464 | 0.120 |
Why?
|
| Atrial Flutter | 2 | 2015 | 44 | 0.120 |
Why?
|
| Transgenes | 1 | 2017 | 316 | 0.120 |
Why?
|
| Mortality | 3 | 2009 | 264 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 2000 | 441 | 0.120 |
Why?
|
| Fasting | 3 | 2014 | 303 | 0.120 |
Why?
|
| Postpartum Period | 1 | 2018 | 245 | 0.120 |
Why?
|
| Antihypertensive Agents | 3 | 2015 | 414 | 0.120 |
Why?
|
| Adenoma | 1 | 2017 | 144 | 0.120 |
Why?
|
| Transaminases | 2 | 2014 | 38 | 0.120 |
Why?
|
| Vulnerable Populations | 1 | 2018 | 151 | 0.120 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2016 | 22 | 0.120 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2016 | 26 | 0.120 |
Why?
|
| C-Reactive Protein | 6 | 2014 | 450 | 0.120 |
Why?
|
| Endothelium, Vascular | 2 | 2011 | 468 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 1 | 2016 | 226 | 0.110 |
Why?
|
| Vulvar Neoplasms | 1 | 2015 | 18 | 0.110 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 172 | 0.110 |
Why?
|
| Thyroid Neoplasms | 1 | 2017 | 241 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 514 | 0.110 |
Why?
|
| Blood Flow Velocity | 3 | 2012 | 417 | 0.110 |
Why?
|
| Troponin I | 1 | 2016 | 122 | 0.110 |
Why?
|
| Age Factors | 8 | 2014 | 2825 | 0.110 |
Why?
|
| Chromatography, Liquid | 3 | 2011 | 235 | 0.110 |
Why?
|
| Atrial Remodeling | 1 | 2014 | 16 | 0.110 |
Why?
|
| Sex Distribution | 7 | 2012 | 318 | 0.100 |
Why?
|
| Logistic Models | 6 | 2017 | 1797 | 0.100 |
Why?
|
| Genetic Vectors | 1 | 2017 | 892 | 0.100 |
Why?
|
| Carbon Monoxide | 1 | 2014 | 26 | 0.100 |
Why?
|
| Angiopoietin-2 | 2 | 2012 | 11 | 0.100 |
Why?
|
| Receptor, TIE-2 | 2 | 2012 | 12 | 0.100 |
Why?
|
| Myocardial Infarction | 4 | 2015 | 999 | 0.100 |
Why?
|
| United States | 16 | 2017 | 12072 | 0.100 |
Why?
|
| Age Distribution | 6 | 2014 | 422 | 0.100 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 209 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2011 | 289 | 0.100 |
Why?
|
| Heart Murmurs | 2 | 2013 | 12 | 0.100 |
Why?
|
| Time Factors | 10 | 2015 | 6196 | 0.100 |
Why?
|
| Caffeine | 2 | 2010 | 66 | 0.100 |
Why?
|
| Models, Cardiovascular | 1 | 2014 | 165 | 0.090 |
Why?
|
| Magnesium Deficiency | 1 | 2012 | 10 | 0.090 |
Why?
|
| Carotid Artery Diseases | 2 | 2015 | 130 | 0.090 |
Why?
|
| Carcinoma | 1 | 2015 | 291 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2017 | 713 | 0.090 |
Why?
|
| Triglycerides | 4 | 2009 | 602 | 0.090 |
Why?
|
| Heart Atria | 3 | 2010 | 343 | 0.090 |
Why?
|
| Sarcoma | 1 | 2015 | 219 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 2 | 2011 | 170 | 0.090 |
Why?
|
| Homes for the Aged | 1 | 1992 | 21 | 0.090 |
Why?
|
| Blood Glucose | 3 | 2016 | 1117 | 0.090 |
Why?
|
| Schizophrenia | 2 | 2005 | 324 | 0.090 |
Why?
|
| Stress, Psychological | 3 | 2007 | 536 | 0.090 |
Why?
|
| HIV Infections | 2 | 2005 | 2049 | 0.090 |
Why?
|
| Prognosis | 8 | 2015 | 4886 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2012 | 47 | 0.090 |
Why?
|
| Nursing Homes | 1 | 1992 | 88 | 0.090 |
Why?
|
| Cause of Death | 6 | 2013 | 506 | 0.090 |
Why?
|
| Menopause | 1 | 2012 | 85 | 0.090 |
Why?
|
| Neuropsychological Tests | 5 | 2007 | 960 | 0.090 |
Why?
|
| Prevalence | 7 | 2021 | 2701 | 0.090 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2014 | 325 | 0.090 |
Why?
|
| Leukocyte Count | 1 | 2011 | 246 | 0.080 |
Why?
|
| Overweight | 3 | 2013 | 387 | 0.080 |
Why?
|
| Pedigree | 4 | 2020 | 1677 | 0.080 |
Why?
|
| Insulin | 2 | 2014 | 1149 | 0.080 |
Why?
|
| Brachial Artery | 1 | 2011 | 34 | 0.080 |
Why?
|
| Kidney Function Tests | 1 | 2011 | 135 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2010 | 67 | 0.080 |
Why?
|
| Dietary Fiber | 1 | 2010 | 78 | 0.080 |
Why?
|
| Young Adult | 8 | 2018 | 10103 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 33 | 0.080 |
Why?
|
| Regression Analysis | 5 | 2016 | 761 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 1992 | 362 | 0.080 |
Why?
|
| Educational Status | 3 | 2006 | 279 | 0.080 |
Why?
|
| Vasodilation | 1 | 2011 | 175 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 14 | 0.080 |
Why?
|
| Quality Control | 1 | 2010 | 116 | 0.080 |
Why?
|
| Tunica Media | 1 | 2009 | 15 | 0.070 |
Why?
|
| Adult Children | 1 | 2009 | 5 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 1586 | 0.070 |
Why?
|
| South Africa | 2 | 2021 | 98 | 0.070 |
Why?
|
| Tunica Intima | 1 | 2009 | 61 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2010 | 278 | 0.070 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2009 | 32 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 44 | 0.070 |
Why?
|
| Substance-Related Disorders | 2 | 2006 | 496 | 0.070 |
Why?
|
| Longevity | 1 | 2010 | 178 | 0.070 |
Why?
|
| Pregnancy | 6 | 2022 | 7512 | 0.070 |
Why?
|
| Reference Standards | 1 | 2009 | 231 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 2833 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 2010 | 190 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2011 | 448 | 0.070 |
Why?
|
| Cholesterol | 3 | 2005 | 539 | 0.070 |
Why?
|
| Odds Ratio | 4 | 2017 | 1211 | 0.070 |
Why?
|
| Risk | 5 | 2011 | 726 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2012 | 810 | 0.070 |
Why?
|
| Lipoproteins, HDL | 1 | 2008 | 97 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 1071 | 0.070 |
Why?
|
| Marriage | 1 | 2007 | 27 | 0.070 |
Why?
|
| Marital Status | 1 | 2007 | 32 | 0.070 |
Why?
|
| Apolipoproteins | 1 | 2007 | 69 | 0.060 |
Why?
|
| Receptors, Leptin | 2 | 2017 | 40 | 0.060 |
Why?
|
| Algorithms | 2 | 2013 | 1680 | 0.060 |
Why?
|
| Genotype | 2 | 2014 | 2595 | 0.060 |
Why?
|
| Hyperhomocysteinemia | 2 | 2004 | 37 | 0.060 |
Why?
|
| Myocardial Contraction | 1 | 2008 | 241 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 1939 | 0.060 |
Why?
|
| Phosphorus | 1 | 2007 | 60 | 0.060 |
Why?
|
| Down Syndrome | 1 | 2009 | 233 | 0.060 |
Why?
|
| Infant, Low Birth Weight | 1 | 2007 | 172 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2009 | 502 | 0.060 |
Why?
|
| Quality of Health Care | 1 | 2010 | 413 | 0.060 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2007 | 80 | 0.060 |
Why?
|
| Mutation | 1 | 2020 | 6099 | 0.060 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2006 | 42 | 0.060 |
Why?
|
| Reference Values | 3 | 2011 | 676 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2010 | 499 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 530 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2015 | 2406 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2007 | 197 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 119 | 0.060 |
Why?
|
| Chromosome Disorders | 1 | 2007 | 316 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2007 | 297 | 0.050 |
Why?
|
| Pre-Eclampsia | 1 | 2007 | 226 | 0.050 |
Why?
|
| Liver | 1 | 2012 | 1796 | 0.050 |
Why?
|
| Boston | 2 | 2005 | 117 | 0.050 |
Why?
|
| Kidney | 1 | 2011 | 1282 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2011 | 1559 | 0.050 |
Why?
|
| Hyperuricemia | 1 | 2004 | 39 | 0.050 |
Why?
|
| Ultrasonography | 4 | 2011 | 943 | 0.050 |
Why?
|
| Hostility | 1 | 2004 | 20 | 0.050 |
Why?
|
| Uric Acid | 1 | 2004 | 110 | 0.050 |
Why?
|
| Anger | 1 | 2004 | 31 | 0.050 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2009 | 986 | 0.050 |
Why?
|
| Adolescent | 8 | 2017 | 20987 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1168 | 0.050 |
Why?
|
| Occupational Diseases | 1 | 2004 | 75 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2011 | 934 | 0.050 |
Why?
|
| Congenital Abnormalities | 1 | 2007 | 330 | 0.050 |
Why?
|
| Confidence Intervals | 3 | 2012 | 272 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 3436 | 0.050 |
Why?
|
| Premature Birth | 1 | 2007 | 428 | 0.050 |
Why?
|
| Infant Death | 1 | 2022 | 2 | 0.050 |
Why?
|
| Self Report | 2 | 2017 | 554 | 0.050 |
Why?
|
| Nepal | 1 | 2022 | 25 | 0.050 |
Why?
|
| Mental Health Services | 1 | 2006 | 285 | 0.050 |
Why?
|
| Alcoholism | 1 | 2005 | 244 | 0.050 |
Why?
|
| Calcium | 1 | 2007 | 1010 | 0.050 |
Why?
|
| Antipsychotic Agents | 1 | 2005 | 375 | 0.040 |
Why?
|
| Creatinine | 2 | 2016 | 398 | 0.040 |
Why?
|
| Adiposity | 2 | 2014 | 209 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2005 | 463 | 0.040 |
Why?
|
| South Dakota | 1 | 2021 | 1 | 0.040 |
Why?
|
| North Dakota | 1 | 2021 | 5 | 0.040 |
Why?
|
| Albuminuria | 2 | 2015 | 107 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2005 | 345 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2004 | 915 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 563 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2012 | 43 | 0.040 |
Why?
|
| Glucose Intolerance | 3 | 2007 | 80 | 0.040 |
Why?
|
| Survival Rate | 3 | 2014 | 2114 | 0.040 |
Why?
|
| Rhode Island | 1 | 2000 | 6 | 0.040 |
Why?
|
| Mathematical Computing | 1 | 2000 | 9 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2001 | 107 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2012 | 3147 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2000 | 103 | 0.040 |
Why?
|
| Firearms | 1 | 2001 | 59 | 0.040 |
Why?
|
| Interview, Psychological | 1 | 2000 | 101 | 0.040 |
Why?
|
| Surveys and Questionnaires | 3 | 2010 | 4066 | 0.040 |
Why?
|
| Comorbidity | 4 | 2005 | 1595 | 0.040 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2010 | 102 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 352 | 0.040 |
Why?
|
| Cholesterol, LDL | 3 | 2007 | 604 | 0.040 |
Why?
|
| Urban Population | 1 | 2001 | 287 | 0.040 |
Why?
|
| Organ Size | 2 | 2010 | 407 | 0.040 |
Why?
|
| Inflammation | 4 | 2010 | 1489 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2017 | 17753 | 0.030 |
Why?
|
| Population Surveillance | 3 | 2008 | 396 | 0.030 |
Why?
|
| Health Behavior | 1 | 2001 | 387 | 0.030 |
Why?
|
| Heredity | 1 | 2017 | 16 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2017 | 96 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2001 | 398 | 0.030 |
Why?
|
| Cytokines | 1 | 2003 | 1339 | 0.030 |
Why?
|
| Indians, North American | 1 | 2017 | 71 | 0.030 |
Why?
|
| Sex Characteristics | 2 | 2012 | 323 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 176 | 0.030 |
Why?
|
| Dependovirus | 1 | 2017 | 160 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2016 | 94 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 217 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 775 | 0.030 |
Why?
|
| Ethanol | 1 | 2017 | 170 | 0.030 |
Why?
|
| Pulse Wave Analysis | 1 | 2015 | 48 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 77 | 0.030 |
Why?
|
| Infant | 2 | 2022 | 13352 | 0.030 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2015 | 35 | 0.030 |
Why?
|
| SMARCB1 Protein | 1 | 2015 | 42 | 0.030 |
Why?
|
| Registries | 1 | 2022 | 1634 | 0.030 |
Why?
|
| Non-Nutritive Sweeteners | 1 | 2014 | 1 | 0.030 |
Why?
|
| Nutritive Sweeteners | 1 | 2014 | 2 | 0.030 |
Why?
|
| Molecular Biology | 1 | 2015 | 66 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 2014 | 21 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 2085 | 0.030 |
Why?
|
| Propensity Score | 1 | 2015 | 271 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 2014 | 82 | 0.030 |
Why?
|
| Mediator Complex | 1 | 2014 | 62 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2017 | 487 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 287 | 0.030 |
Why?
|
| Demography | 2 | 2005 | 237 | 0.030 |
Why?
|
| Fetus | 1 | 2017 | 568 | 0.030 |
Why?
|
| Breath Tests | 1 | 2014 | 182 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 743 | 0.020 |
Why?
|
| Heart Rate | 1 | 2016 | 577 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 414 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2000 | 1050 | 0.020 |
Why?
|
| Gestational Age | 1 | 2017 | 1224 | 0.020 |
Why?
|
| Genetic Testing | 2 | 2010 | 1106 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2014 | 353 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 716 | 0.020 |
Why?
|
| Interleukin-6 | 2 | 2006 | 412 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2000 | 878 | 0.020 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2011 | 5 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 801 | 0.020 |
Why?
|
| England | 1 | 2011 | 60 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 1133 | 0.020 |
Why?
|
| Radioisotope Dilution Technique | 1 | 2011 | 37 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1591 | 0.020 |
Why?
|
| Potassium | 1 | 2012 | 263 | 0.020 |
Why?
|
| Disease Progression | 2 | 2010 | 2200 | 0.020 |
Why?
|
| Peripheral Arterial Disease | 1 | 2015 | 326 | 0.020 |
Why?
|
| Patient Admission | 1 | 1992 | 185 | 0.020 |
Why?
|
| Seafood | 1 | 2010 | 10 | 0.020 |
Why?
|
| Fishes | 1 | 2010 | 32 | 0.020 |
Why?
|
| Data Collection | 2 | 2005 | 370 | 0.020 |
Why?
|
| Community Health Services | 1 | 2011 | 86 | 0.020 |
Why?
|
| Colorimetry | 1 | 2010 | 16 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2010 | 98 | 0.020 |
Why?
|
| Systole | 1 | 2010 | 195 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 987 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 191 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2010 | 110 | 0.020 |
Why?
|
| Phenotype | 2 | 2011 | 4497 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 1882 | 0.020 |
Why?
|
| Europe | 1 | 2010 | 365 | 0.020 |
Why?
|
| Child | 2 | 2022 | 26341 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2015 | 12936 | 0.020 |
Why?
|
| Carotid Artery, Internal | 1 | 2009 | 55 | 0.020 |
Why?
|
| Carotid Artery, Common | 1 | 2009 | 59 | 0.020 |
Why?
|
| Observer Variation | 1 | 2010 | 311 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 373 | 0.020 |
Why?
|
| Community Participation | 1 | 2009 | 42 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2010 | 461 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 566 | 0.020 |
Why?
|
| Sucrose | 1 | 2007 | 35 | 0.020 |
Why?
|
| Apolipoprotein A-I | 1 | 2007 | 80 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2007 | 116 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2007 | 37 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2010 | 295 | 0.020 |
Why?
|
| Apolipoproteins B | 1 | 2007 | 142 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2008 | 729 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2007 | 117 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2010 | 256 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 541 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 3061 | 0.010 |
Why?
|
| Inactivation, Metabolic | 1 | 2006 | 25 | 0.010 |
Why?
|
| Hypertriglyceridemia | 1 | 2007 | 117 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 49 | 0.010 |
Why?
|
| Occupations | 1 | 2005 | 17 | 0.010 |
Why?
|
| P-Selectin | 1 | 2006 | 69 | 0.010 |
Why?
|
| Pyridoxine | 1 | 2005 | 15 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 125 | 0.010 |
Why?
|
| Hemostasis | 1 | 2006 | 77 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2006 | 112 | 0.010 |
Why?
|
| Particle Size | 1 | 2005 | 135 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2550 | 0.010 |
Why?
|
| Methadone | 1 | 2006 | 135 | 0.010 |
Why?
|
| Vitamin B 12 | 1 | 2005 | 59 | 0.010 |
Why?
|
| Narcotic Antagonists | 1 | 2006 | 112 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 306 | 0.010 |
Why?
|
| Anthropometry | 1 | 2005 | 187 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2005 | 260 | 0.010 |
Why?
|
| Emotions | 1 | 2007 | 350 | 0.010 |
Why?
|
| Energy Intake | 1 | 2007 | 502 | 0.010 |
Why?
|
| Motor Activity | 1 | 2007 | 489 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2006 | 191 | 0.010 |
Why?
|
| Type A Personality | 1 | 2004 | 3 | 0.010 |
Why?
|
| Life Style | 1 | 2007 | 456 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 2004 | 17 | 0.010 |
Why?
|
| Social Class | 1 | 2006 | 214 | 0.010 |
Why?
|
| Lipids | 1 | 2007 | 569 | 0.010 |
Why?
|
| Language | 1 | 2005 | 219 | 0.010 |
Why?
|
| Job Satisfaction | 1 | 2004 | 100 | 0.010 |
Why?
|
| Folic Acid | 1 | 2005 | 269 | 0.010 |
Why?
|
| Morbidity | 1 | 2004 | 256 | 0.010 |
Why?
|
| History, 21st Century | 1 | 2004 | 263 | 0.010 |
Why?
|
| Personality Inventory | 1 | 2004 | 179 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2904 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2004 | 365 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 2002 | 56 | 0.010 |
Why?
|
| Recurrence | 1 | 2006 | 1489 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2007 | 715 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 354 | 0.010 |
Why?
|
| Parents | 1 | 2009 | 1128 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2004 | 431 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 1129 | 0.010 |
Why?
|
| Diet | 1 | 2007 | 1121 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2002 | 230 | 0.010 |
Why?
|
| Anxiety | 1 | 2005 | 1014 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 2885 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 4686 | 0.010 |
Why?
|
| Software | 1 | 2000 | 733 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2007 | 8635 | 0.010 |
Why?
|
| Animals | 1 | 2010 | 33912 | 0.000 |
Why?
|
| Neoplasms | 1 | 2004 | 3016 | 0.000 |
Why?
|